Vivet Therapeutics to Present Key Findings on its Gene Therapy Program forCerebrotendinous Xanthomatosis at the American Association for the Study of Liver Diseases Annual Meeting
Paris, France, November 14, 2024 – Vivet Therapeutics (“Vivet”), a clinical stage biotechcompany developing novel and long-lasting gene therapies for rare inherited liver metabolicdisorders, today announces that it will be presenting key pre-clinical findings for VTX-806, itsgene therapy program for the treatment of Cerebrotendinous Xanthomatosis (CTX), at TheLiver Meeting presented by the American Association for […]
Vivet Therapeutics is heading west for The Liver Meeting in sunny ☀ San Diego, California!
📢 @Vivet Therapeutics is heading west for The Liver Meeting in sunny ☀ San Diego, California! ⛱ Listen in as #Vivet’s Co-founder & Chief Scientific Officer, Dr @Gloria Gonzalez-Aseguinolaza presents 🎤 key findings on #VTX-806, our gene therapy program for Cerebrotendinous Xanthomatosis (#CTX) at The Liver Meeting (#TLM) presented by the @American Association for the […]
🎉 Vivet Therapeutics is heading to Stockholm for BIO-Europe! 🎉
Join our Co-Founder & Chief Executive Officer, @Jean-Philippe Combal, and @Susan Coles, General Counsel and Head of Finance at #BIOEurope2024 in Stockholm, Sweden from 4-6 November. Don’t miss the opportunity to connect 🤝with Jean-Philippe and Susan to learn more about #Vivet’s disruptive development engine and its diversified pipeline. Celebrating its 30th year, #BIOEurope, presented by […]
Australasian Gene & Cell Therapy Biennial Meeting
📣#VivetTherapeutics is headed to the land down under!📣 Join our Co-Founder and CSO, Dr @Gloria Gonzalez-Aseguinolaza at the Australasian Gene and Cell Therapy Society (#ASGCT) Biennial Meeting in Sydney, Australia from 30 October – 1 November. Don’t miss this excellent opportunity to listen👂in as Gloria provides insight into gene editing for the treatment of inherited […]
💗Pink October💗
In collaboration with @Courir pour Elles, @Vivet_tx participated in an 8km walk/run to raise #BreastCancer Awareness and Prevention. Join #TeamVivet in the cause as we rack up steps👟for #CourirPourElles’ 💗Pink 💗Challenge during #PinkOctober. Also known as ‘le Défi Rose’, the Challenge helps raise #BreastCancerAwareness and highlights the role a healthy lifestyle plays in #cancer prevention.
Inaugural Cell & Gene Therapy Regulatory Affairs Summit presented by @HansonWade, from 28 – 30 October in 🏦 Washington, D.C.!
Connect with Co-Founder & CEO, @Jean-Philippe Combal & Director of Regulatory Affairs & Quality Assurance, @Annelise Brossel at the inaugural Cell & Gene Therapy Regulatory Affairs Summit presented by @HansonWade, from 28 – 30 October in 🏦 Washington, D.C.! Get in touch to schedule a meeting with the team or you can find Jean-Philippe and […]
Vivet Therapeutics Presents Three Posters on Cerebrotendinous Xanthomatosis Program and Novel AAV Gene Delivery Platform at European Society of Gene and Cell Therapy Annual Congress 2024
Paris, France, October 22, 2024 – Vivet Therapeutics (“Vivet”), a clinical stage biotech company developing novel and long-lasting gene therapies for rare inherited liver metabolic disorders, today announces the presentation of three posters demonstrating key pre-clinical findings for its gene therapy program, VTX-806 for the treatment of Cerebrotendinous Xanthomatosis (CTX), a study on S/MAR-containing AAV vector […]
Who’s excited about the @World Orphan Drug Congress Europe 2024🌍taking place in Spain from 22-25 October?
With over 25 years of expertise in #drugdevelopment, our Head of Clinical Operations & Patient Advocacy Representative, @Sonia Valero, will join industry leaders on a panel 📢 to share valuable insights on the “Convergence on Rare Disease and Precision Medicine – a Real Drive on Drug Development.” 📅 Date: Wednesday 23rd October 2024 🕘 Time: […]
🎓Are you attending the upcoming 2024 @European Society of Gene and Cell Therapy (#ESGCT) Congress, from 22-25 October in Rome, Italy?
Don’t miss the opportunity to meet the @Vivet Therapeutics leadership team who will be participating in a jam-packed schedule at the event. 👂Listen in as our Co-Founder and CSO, Dr @Gloria Gonzalez Aseguinolaza deliberates on the latest developments in gene therapy for liver disease in an oral presentation and panel discussion. Also check out our […]
🎉 25th Anniversary of the Spanish Society of Gene🧬& Cell🦠Therapy! 🎉
🎉 25th Anniversary of the Spanish Society of Gene🧬& Cell🦠Therapy! 🎉 Join our Co-Founder & Chief Scientific Officer, Dr @Gloria Gonzalez-Aseguinolaza in celebrating this special occasion at the @Fundacion Botín in Madrid, Spain from October 7– 8. Don’t miss the opportunity to hear insights from Gloria – a @Rosalind Franklin Society Special Award laureate and […]
